Click on the Popdown menu in your area of interest for a list of related articles and select the article of your choice

Heart Health / Stroke Prevention  Congestive Heart Failure Calcium Channel Blockers Hypertension Stroke Prevention	Psychiatry  Antidepressants- the SSRI's  Attention Deficit/ Hyperactivity  Sleep and Aging
Neurology  ReQuip-New Safety Infos  Multiple Sclerosis  Parkinson's Disease  Epilepsy  Tasmar- sales suspended	Endocrinology (hormones)  Diabetes- non insulin dependent  Estrogen replacement therapy  Premarin patient information  Thyroid Replacement  Menopause
Gastroenterology  Crohn's / Colitis	Infectious Diseases  Anthrax Herpes Update (shingles)  Herpes(shingles)  Tuberculosis
Medicinal Herbs  Herbs and blood coagulation St. Johns Wort drug interactionsMedicinal Herbs	Miscellaneous  Chronic pain management

Herbal Products Which May Affect Blood CoagulationClick Here for details

From the NewsWire

Early Initiation of Treatment Delays Development of Multiple Sclerosis

The results of a clinical trial examining the efficacy
of interferon-beta-1a (Avonex ) in patients at high
risk of developing clinically definite multiple
sclerosis (CDMS) were reported during the Late
Breaking News: MS Platform Session held May 1,
2000. at the 52nd Annual Meeting of the American
Academy of Neurology, San Diego. California.
In an interview after the session. Dr. Paul
O'Connor. a Canadian CHAMPS investigator,
stated, "These interesting and exciting results
suggest that interferons work best in MS when
given earlier rather than later in the disease,"